LifeMD
LFMD
63 hedge funds and large institutions have $78.5M invested in LifeMD in 2021 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 12 closing their positions.
108% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 12
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
26% more funds holding
Funds holding: 50 → 63 (+13)
7% more ownership
Funds ownership: 18.51% → 25.51% (+7%)
4% more capital invested
Capital invested by funds: $75.2M → $78.5M (+$3.38M)
31% less call options, than puts
Call options by funds: $11.2M | Put options by funds: $16.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Ophir Asset Management
Sydney,
Australia
|
+$11.6M |
| 2 |
Two Sigma Advisers
New York
|
+$5.32M |
| 3 |
Two Sigma Investments
New York
|
+$5.22M |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$2.8M |
| 5 |
Millennium Management
New York
|
+$2.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$6.72M |
| 2 |
AI
Atom Investors
Austin,
Texas
|
-$5.22M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.67M |
| 4 |
VC
Voss Capital
Houston,
Texas
|
-$1.9M |
| 5 |
MFG
Magnus Financial Group
New York
|
-$833K |
LFMD Hedge Fund Activity: Q2 2021 in Review
63 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q2 2021, worth a combined $78.5M — up 4.5% from $75.2M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new LFMD positions and 12 closed out — a net gain of 13 holders — while 20 added to existing stakes and 12 trimmed.
The largest buyer was Ophir Asset Management, opening a new position worth an estimated $11.6M. The largest seller was Invesco, exiting entirely with an estimated $6.72M sold.
- 63 institutional investors held LifeMD (LFMD) as of Q2 2021, up from 50 in Q1 2021.
- Funds reported $78.5M of LifeMD stock for Q2 2021, up 4.5% quarter-over-quarter.
- 25 funds opened new LifeMD positions in Q2 2021 and 12 closed out, a net change of +13 holders.
- The largest LifeMD buyer in Q2 2021 was Ophir Asset Management, an estimated $11.6M added.
- The largest LifeMD seller in Q2 2021 was Invesco, an estimated $6.72M sold.
Based on aggregated 13F filings for Q2 2021.